DexCom DXCM recently signed a licensing and data partnership with a privately held healthcare-at-home digital diagnostics company — Nanowear. Per the terms of the agreement, Nanowear will use glucose ...

DexCom, Inc. DXCM recently unveiled new data for its upcoming G7 15-day continuous glucose monitoring (CGM) sensor at the Advanced Technologies & Treatments for Diabetes (ATTD) conference 2025. With ...

Amsterdam played host to this year's edition of the International Conference on Advanced Technologies & Treatments for ...

Of the hundreds of millions of people living with diabetes, most liv. Dexcom wants to make sure they have tools to manage it.

HCPs see CGM as the 'standard of care': Half of all HCPs felt CGM should be the standard of care for people with Type 2 diabetes whether they were using insulin to manage the condition or not. 96% of ...

EDINBURGH, Scotland & SAN DIEGO–(BUSINESS WIRE)–DexCom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, today announced the launch of its first multi-region report, the “Dexcom State of ...

Launch of the NovoPen 6 and NovoPen Echo Plus will begin in the first quarter of 2019 and roll out to over 50 countries in the coming years. The new pens will eventually be phased in to replace ...